Trial Profile
Phase I first-in-human trial of SelG1 in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Jul 2017
Price :
$35
*
At a glance
- Drugs Crizanlizumab (Primary)
- Indications Myelofibrosis; Priapism; Vaso-occlusive crisis
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Selexys Pharmaceuticals
- 26 Mar 2014 New trial record